Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis
暂无分享,去创建一个
Yiqing Zhao | J. Willis | A. Khalil | A. Scott | Yujun Hao | Xiujing Feng | Zhenghe Wang | Peng Zhang | Saigopal Somasundaram
[1] Zhenghe Wang,et al. Genetic alterations of protein tyrosine phosphatases in human cancers , 2014, Oncogene.
[2] Kelsey P. Pendleton,et al. Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer , 2014, Proceedings of the National Academy of Sciences.
[3] Yujun Hao,et al. Targeting the Protein–Protein Interaction between IRS1 and Mutant p110α for Cancer Therapy , 2014, Toxicologic pathology.
[4] A. Lane,et al. Control of Glutamine Metabolism By the Tumor Suppressor Rb , 2013, Oncogene.
[5] S. McCall,et al. Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer , 2014, Investigational New Drugs.
[6] Huanming Yang,et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation , 2013, Nature Genetics.
[7] S. Markowitz,et al. Gain of interaction with IRS1 by p110α-helical domain mutants is crucial for their oncogenic functions. , 2013, Cancer cell.
[8] A. McKenna,et al. Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity , 2013, Nature Genetics.
[9] Dennis C. Sgroi,et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes , 2016 .
[10] Jing Pan,et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. , 2012, Carcinogenesis.
[11] C. Turner,et al. Diverse roles for the paxillin family of proteins in cancer. , 2012, Genes & cancer.
[12] Bin Tean Teh,et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.
[13] J. Montero,et al. Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors , 2011, Clinical Cancer Research.
[14] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[15] T. Hunter,et al. Protein kinase signaling networks in cancer. , 2011, Current opinion in genetics & development.
[16] S. Brady-Kalnay,et al. Characterization of the Adhesive Properties of the Type IIb Subfamily Receptor Protein Tyrosine Phosphatases , 2010, Cell communication & adhesion.
[17] Kishore Guda,et al. Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T , 2010, Proceedings of the National Academy of Sciences.
[18] S. Brady-Kalnay,et al. Cancer-Derived Mutations in the Fibronectin III Repeats of PTPRT/PTPρ Inhibit Cell-Cell Aggregation , 2010, Cell communication & adhesion.
[19] Yu Xue,et al. GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy *S , 2008, Molecular & Cellular Proteomics.
[20] C. Turner,et al. Paxillin comes of age , 2008, Journal of Cell Science.
[21] Susann M Brady-Kalnay,et al. Tumor-Derived Extracellular Mutations of PTPRT/PTPρ Are Defective in Cell Adhesion , 2008, Molecular Cancer Research.
[22] Z. Weng,et al. Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies , 2008, Nature Methods.
[23] K. Kinzler,et al. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T , 2007, Proceedings of the National Academy of Sciences.
[24] N. Tonks,et al. Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.
[25] C. Ko,et al. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.
[26] Giovanni Parmigiani,et al. Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.
[27] M. Toosarvandani,et al. Src-dependent association of Cas and p85 phosphatidylinositol 3'-kinase in v-crk-transformed cells. , 2003, Molecular cancer research : MCR.
[28] M. Young,et al. Protein phosphatase‐2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins , 2003, International journal of cancer.
[29] Michael D Schaller,et al. Paxillin: a focal adhesion-associated adaptor protein , 2001, Oncogene.
[30] G. Nemerow,et al. Association of p130CAS with Phosphatidylinositol-3-OH Kinase Mediates Adenovirus Cell Entry* , 2000, The Journal of Biological Chemistry.
[31] C. Turner,et al. Characterization of Tyrosine Phosphorylation of Paxillin in Vitro by Focal Adhesion Kinase (*) , 1995, The Journal of Biological Chemistry.